About
Kaerus Bioscience Limited is a clinical-stage biopharmaceutical company developing targeted small molecule therapeutics for ion channel dysfunctions, focusing on Fragile X syndrome and related rare neurodevelopmental genetic disorders.
Explore Kaerus Bioscience Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.